Ftse Mib
33.707,21
-0,38%
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.686,91
2,36%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Nurexone Biologic Inc (NRX) Nurexone Biologic Inc (NRX) Notizie

Nurexone Biologic Inc

NRX
0,70
-0,03 (-4,11%)
25 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: TSX Venture
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
21/6/202422:04GLOBEOn Path to First-in-Human Study, NurExone Engages Prominent..
11/6/202414:44GLOBENurExone Announces Expansion of ExoPTEN Patent Coverage with..
04/6/202422:40GLOBENurExone Announces Voting Results from 2024 Annual Meeting..
29/5/202414:35GLOBENurExone Reports First Quarter 2024 Financial Results and..
17/5/202422:04GLOBENurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive..
25/4/202417:30APSShares of Biopharma Up After News of Uplisting
25/4/202414:35GLOBENurExone Biologic Inc. Announces Strategic Expansion to US..
19/4/202422:04GLOBENurExone Presenting on Revolutionary Spinal Cord Injury..
02/4/202414:31GLOBENurExone Reports Fourth Quarter and Year Ended December 31,..
27/3/202422:05GLOBEGross Proceeds Close of $4M CAD Generated for NurExone From..
22/3/202422:04GLOBEIn Preparation for Expected Human Clinical Trials, NurExone..
15/3/202421:05GLOBENurExone's Strategic Update: Submission of OTCQB Listing..
08/3/202422:05GLOBENurExone establishing State-of-the-Art Research and..
01/3/202422:04GLOBENurExone Presenting Novel Regulatory Pathways for Exosomes..
20/2/202422:05GLOBENurExone’s Intellectual Property Portfolio Expands
14/2/202422:20GLOBENurExone Launches Licensing Efforts for ExoTherapy Platform
02/2/202422:05GLOBENurexone Biologic Initiates European Orphan Drug Designation..
17/1/202414:34GLOBENurExone and Inteligex Kick Off Chronic Spinal Cord Injury..
05/1/202414:30GLOBENurExone Announces Closing of a Private Placement for Gross..
29/11/202314:30GLOBENurExone Biologic Extends Spinal Cord Injury Therapy..
24/11/202314:30GLOBENurExone Reports Third Quarter 2023 Financial Results and..
16/11/202322:21APSTake Part in the Next Generation of Spinal Cord Injury..
07/11/202322:01APSOrphan Drugs Worth $64 Billion by 2028 and This Micro Cap..
31/10/202322:00APSWhen Technicals and Fundamentals Converge, A Nice Uptrend..
30/10/202318:00APSShares Up Following Orphan Drug Designation
30/10/202314:20GLOBENurExone Biologic Receives FDA Orphan-Drug Designation,..
25/10/202323:18APSMicrocap Offers Unique Opportunity for Investors In $10..
19/10/202314:30GLOBEAppointment of Professor Teo Forcht Dagi to Scientific..
18/10/202323:07APSNew Collaboration Could Revolutionize Treatment of Chronic..
11/10/202316:00APSSmall Company Working on Big Breakthrough in Treating Spinal..
11/10/202314:30GLOBENurExone Secures Eureka Grant for Collaborative..
05/10/202314:30GLOBENurExone Biologic to Present Exosome-Based Therapy for..
28/9/202314:30GLOBENurExone Appoints Dr. Reuter Investor Relations in Europe
13/9/202314:30GLOBENurExone Moves Forward Towards Human Clinical Trials,..
06/9/202314:30GLOBENurExone Announces Closing of Second Tranche of Private..
09/8/202314:00GLOBENurExone Announces Private Placement
20/7/202314:15GLOBENurExone Biologic Announces Advancements in Extracellular..
Apertura: 0,68 Min: 0,68 Max: 0,71
Chiusura: 0,73

La tua Cronologia

TSXV
NRX
Nurexone Biologic
TG
9GAF
WisdomTree Commodity Sec...
COIN
LNDUSD
Lendingblock
BIT
P21J59
NLBNPIT21J59 20240918 1900
BOV
EGIE3M
ENGIE BRASIL ON
LSE
MF01
Sg_ukx_mf01
EU
CADCP
Cades CADESFRN27FEB24
TG
CWY
Clearmind Medicine
EU
BIOEG
Euronext Euro Large Cap ...
USOTC
QSCGF
Q Beyond (PK)
TSX
QQQT.U
Evolve NASDAQ Techology
TG
4F31
Forestar
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network